STAT+ Conversations

Biotech Kate Sheridan

STAT Plus: STAT+ Conversations: A conversation with a leading biotech venture capitalist

In the Lab Nicholas St. Fleur

STAT Plus: STAT+ Conversations: A conversation on race, science, and advocacy with Black in Neuro founder Angeline Dukes

Biotech Megan Thielking

STAT Plus: STAT+ Conversations: A conversation on the FDA’s regulation of AI

Health Nicholas St. Fleur

STAT Plus: STAT+ Conversations: A conversation on racial health disparities, Covid-19, and vaccine distribution

Health Matthew Herper

STAT Plus: STAT+ Conversations: A conversation with vaccine expert Paul Offit

Politics Erin Mershon

STAT Plus: STAT+ Conversations: What to watch in a Biden White House and a new Congress

Health Tech Casey Ross and Erin Brodwin

STAT Plus: STAT+ Conversations: The health tech news to watch at CES 2021

Health Helen Branswell

STAT Plus: STAT+ Conversations: A (continued) conversation on the Covid-19 vaccine rollout

Biotech Damian Garde

STAT Plus: STAT+ Conversations: A conversation with Nobel laureate Charles Rice

Health Helen Branswell

STAT Plus: STAT+ Conversations: Talking through the vaccine rollout

Morning Rounds Shraddha Chakradhar

STAT Plus: STAT+ Conversations: A Morning Rounds year-in-review

Pharmalot Ed Silverman

STAT Plus: STAT+ Conversations: A conversation on drug pricing, policy, and access

Biotech Adam Feuerstein and Damian Garde

STAT Plus: STAT+ Conversations: What to expect on the FDA’s review of Biogen’s Alzheimer’s treatment

Health Tech Erin Brodwin

STAT Plus: STAT+ Conversations: A conversation with Amwell

Health Casey Ross

STAT Plus: STAT+ Conversations: Beyond real-world data and Covid-19

Health Helen Branswell

STAT Plus: STAT+ Conversations: The Covid-19 pandemic and the race for vaccines

Pharmalot Ed Silverman

STAT Plus: STAT+ Conversations: An update from STAT’s Pharmalot

Biotech Damian Garde

STAT Plus: STAT+ Conversations: How Covid-19 will change drug development

D.C. Diagnosis STAT Staff

STAT Plus: STAT+ Conversations: The D.C. Diagnosis

First Opinion STAT Staff

STAT Plus: STAT+ Conversations: An inside look at STAT’s First Opinion

Health Tech Rebecca Robbins

STAT Plus: STAT+ Conversations: How the Chan Zuckerberg Initiative is prioritizing its funding for the Covid-19 response

Health Tech Rebecca Robbins

STAT Plus: STAT+ Conversations: 23andMe CEO says spit kit sales are picking up during the Covid-19 pandemic

STAT+ Conversations Rick Berke, Erin Mershon and Lev Facher

STAT Plus: STAT+ Conversations: How pharma is influencing the 2020 election

Biotech STAT Staff

STAT Plus: STAT+ Conversations: Which biotech venture capitalist funds are performing best?

Health Tech Rebecca Robbins and Erin Brodwin

STAT Plus: STAT+ Conversations: AI’s march into the clinic

Health Andrew Joseph

STAT Plus: STAT+ Conversations: A philosopher’s perspective on facing brain cancer in the time of Covid-19

STAT+ Conversations Matthew Herper

STAT Plus: Eli Lilly’s Dan Skovronsky on Covid-19, Alzheimer’s, and the place of entrepreneurs in pharma

Pharmalot Ed Silverman

STAT Plus: STAT+ Conversations: The state of the pharmaceutical industry, featuring Pharmalot’s Ed Silverman

Biotech Adam Feuerstein, Damian Garde and Rebecca Robbins

STAT+ Conversations: The Readout LOUD, Live!